ANI Pharmaceuticals, Inc. (ANIP)
ANI Pharmaceuticals Market Cap : 1.674B for March 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| CorMedix, Inc. | 494.06M |
| Catalyst Pharmaceuticals, Inc. | 2.783B |
| Castle Biosciences, Inc. | 743.28M |
| Liquidia Corp. | 3.208B |
| Allogene Therapeutics, Inc. | 465.19M |
Market Cap Related Metrics
| PE Ratio | 22.28 |
| PS Ratio | 1.759 |
| Price to Book Value | 3.095 |
| Price to Free Cash Flow | 10.29 |
| Price | 74.67 |
| Earnings Yield | 4.49% |
| Operating PE Ratio | 19.13 |
| Normalized PE Ratio | 33.30 |